Avidity Biosciences, Inc. (NASDAQ:RNA - Get Free Report) has earned an average rating of "Hold" from the sixteen analysts that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, eleven have assigned a hold recommendation, three h